Infrastructure & Libraries


  • Four different HTS systems with a variety of HTS, uHTS and HCS analysis operations

  • Development of new HTS/uHTS and cell microarray based chemical biology technologies

  • Screening of known drugs for pharmacogenomics on patient-derived cell lines

  • Nationally coordinated academic access to state-of-the-art chemoinformatics software as well as expertise with custom program development

  • Access to CSC supercomputing capabilities


We provide access to a shared small molecule collection of over 120 000 drugs and drug-like compounds that are ready to use for screening.  The chemical collections can be divided into two major classes: drugs & known bioactives and chemical diversity libraries.  The drugs and known bioactives are ideal for biological profiling, drug repositioning and personalized medicine-type screens while the larger chemical diversity collections are best suited for molecular probe discovery screening.  In addition, there is access to genomic libraries.

The drug and known bioactive collections include

The chemical diversity collections include 

  • Chembridge CNS-Set (10 000 compounds)

  • ChemDiv chemical diversity collections (25 000 + 25 000 compounds)

  • Specs Consortium collection (30 000 compounds)

  • Tripos diversity collection (6 000 compounds)

The genomic libraries include



Biocenter FinlandFIMM logo.tiffUEF logo.tiffHY logo.tiffAA logo.tiffCSC logo.tiffVTT logo.tiff